Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.

scientific article published in June 1998

Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1089/THY.1998.8.553
P698PubMed publication ID9669297
P5875ResearchGate publication ID13616237

P50authorMario SalviQ60311689
P2093author name stringKubota S
Swanson J
Gunji K
Wall JR
Kiljanski J
Bednarczuk T
Wengrowicz S
P433issue6
P921main subjecteye diseaseQ3041498
P304page(s)553-556
P577publication date1998-06-01
P1433published inThyroidQ15709940
P1476titleRole of the eye muscles in thyroid eye disease: identification of the principal autoantigens
P478volume8

Reverse relations

cites work (P2860)
Q51540617Constitutively low expression of collagen XIII alpha 1 may help explain the vulnerability of the inferior rectus muscle to thyroid-associated ophthalmopathy.
Q35785121Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Q37175812Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease
Q47641586Graves' ophthalmopathy and atrophic thyroiditis: a case report
Q77326677Has the target autoantigen for Graves' ophthalmopathy been found?
Q46881746No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED).
Q33363254Overexpression of collagen XIII in extraocular fat affected by active thyroid-associated ophthalmopathy: A crucial piece of the puzzle?
Q53668615Proteomic surveillance of putative new autoantigens in thyroid orbitopathy.
Q33793183Radioiodine and thyroid-associated ophthalmopathy: from the myth to the reality
Q34014939Thyroid associated orbitopathy following periocular surgery
Q34083395Thyroid autoantibodies
Q34147441Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management

Search more.